Anti-TBC1D3F antibodies are used in the immunodetection of the protein TBC1 domain family member 3F. In humans, the canonical protein has a reported length of 549 amino acid residues and a mass of 62.2 kDa. Its subcellular localization is in the cell membrane. It is reported to be expressed in most tissues including pancreas, thymus and testis. TBC1D3F is known to act as a GTPase activating protein for RAB5. Post-translational modifications have been described, including ubiquitination and palmitoylation. Synonyms for this target antigen include prostate cancer gene 17 protein and protein TRE17-alpha. Some TBC1D3F antibodies may have been used in research and have associated citations. Western Blot is a widely used application for these antibodies. In addition, ELISA is also a common application.